LianBio

Health

LianBio Announces Results from Phase 3 EXPLORER-CN Trial of

Globe News Wire Aug 29, 2023

EXPLORER-CN data presented in oral late-breaking science session at ESC 2023Data from the trial published simultaneously in JAMA CardiologyMavacamten demonstrated improvement in Valsalva LVOT peak gradient, LVOT obstruction, clinical…

Health

LianBio to Participate in Upcoming Investor Conferences

Globe News Wire Jun 2, 2023

SHANGHAI, China and PRINCETON, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that…

Health

LianBio Announces China National Medical Products

Globe News Wire Apr 22, 2023

SHANGHAI, China and PRINCETON, N.J., April 21, 2023 (GLOBE…

Health

LianBio Promotes Pascal Qian to Chief Commercial Officer

Globe News Wire Apr 22, 2023

SHANGHAI, China and PRINCETON, N.J., April 21, 2023 (GLOBE…

- Advertisement -

Health

LianBio Announces President and Chief Strategy Officer

Globe News Wire Dec 14, 2022

SHANGHAI, China and PRINCETON, N.J., Dec. 13, 2022 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that…